Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
February 29, 2000
Conditions
Fanconi's Anemia
Interventions
DRUG
anti-thymocyte globulin
DRUG
cyclophosphamide
DRUG
cyclosporine
DRUG
filgrastim
DRUG
fludarabine
DRUG
methylprednisolone
Trial Locations (1)
55455
University of Minnesota Cancer Center, Minneapolis
All Listed Sponsors
lead
University of Minnesota
OTHER
NCT00005898 - Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia | Biotech Hunter | Biotech Hunter